Compare APEI & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APEI | ARDX |
|---|---|---|
| Founded | 1991 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 875.2M | 797.8M |
| IPO Year | 2007 | 2014 |
| Metric | APEI | ARDX |
|---|---|---|
| Price | $48.69 | $3.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $62.83 | $12.90 |
| AVG Volume (30 Days) | 200.1K | ★ 3.9M |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 147.27 | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | ★ $198,174,000.00 | $2,607,000.00 |
| Revenue This Year | $6.88 | $19.98 |
| Revenue Next Year | $5.93 | $27.70 |
| P/E Ratio | $33.42 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.20 | $3.05 |
| 52 Week High | $61.59 | $8.40 |
| Indicator | APEI | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 61.92 | 36.16 |
| Support Level | $46.79 | N/A |
| Resistance Level | $59.32 | $3.35 |
| Average True Range (ATR) | 1.30 | 0.14 |
| MACD | 0.21 | 0.01 |
| Stochastic Oscillator | 73.08 | 14.19 |
American Public Education Inc provides online and campus based postsecondary education including various undergraduate and graduate degree programs. The fields of study include business administration, health science, technology, criminal justice, education, liberal arts, national security, military studies, intelligence, and homeland security. There are three reporting segments: the American Public University segment which is the key revenue generator, provides online postsecondary education as a distance-learning, graduate-level institution for military officers seeking a degree in military studies; the Rasmussen University Segment and the Hondros College of Nursing segment. The revenue is generated from net course registrations and enrollment, tuition rate, net tuition, and other fees.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.